Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 3,721–3,780 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

Chinhoyi Provincial Hospital1 Chittaranjan National Cancer Institute1 Chong et al1 Chongqing Liangjiang Minsheng Hospital1 Chongqing Medical University Medical Data Science Academy1 Chongqing Songshan Hospital1 Chongqing University1 Chongqing University’s Affiliated Hospital1 Chongqing VIP Database1 Chonnam National University Hospital1 Choosing Wisely Canada1 Chris Hani Baragwanath Academic Hospital1 Chris Hani Baragwanath Academic Hospital Hand Clinic1 Chris Hani Baragwanath Hospital1 Christ Church1 Christchurch Health and Development Study1 Christchurch hospital1 Chulalongkorn University1 Chung-Ang University Gwangmyeong Hospital1 Chung-Ang University Hospital1 Churchill Hospital1 CiNii Research1 Cincinnati Children’s Hospital Medical Center1 Cincinnati Children’s Medical Center1 Cipto Mangunkusumo Hospital1 Circ Cardiovasc Imaging1 Circle Cardiovascular Imaging1 Circulation Research1 City Hospital1 City St George’s University of London1 City of Hope1 City of Hope Institutional Animal Care and Use Committee1 Clare College1 Clarivate–Web of Science1 Class A Tertiary Hospitals1 Class III Grade A hospital1 Clatterbridge Hospital1 Cleveland Clinic Brain Aneurysm Archive1 Cleveland Clinic Institutional Review Board1 Cleveland Clinic’s Institutional Review Board1 Cliff ERS1 Clin Cancer Research1 Clin Neurol Neurosurg1 Clin Sci1 Clinic Barcelona1 Clinic for Nephrology and Clinical Immunology1 Clinic for Traumatology1 Clinica Colonia1 Clinical Analysis Department1 Clinical Center of Montenegro1 Clinical Decision Unit1 Clinical Events Committee1 Clinical Genomics1 Clinical Hospital Zagreb1 Clinical Nutrition Clinic1 Clinical Pathology laboratory1 Clinical Pharmacogenetic Implementation Consortium1 Clinical Pharmacogenetics Implementation Consortium1 Clinical Pharmacology Research Center1 Clinical Research Ethics Committee of Guangdong Provincial Maternal and Child Health Hospital1

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 312 of 946

521 Correlative analysis of a phase I study of autologous activated NK Cells ± rhIL-15 in children and young adults with refractory solid tumors

jitc · abstract · 2025-11-04 · 2 matching annotations

93.7%

National Cancer Institute NCI rhIL-15 solid tumors relapsed/refractory solid tumors NK cell immunotherapies cyclophosphamide

…his study was approved by the Institutional Review Board of the National Cancer Institute (NCI) at the NIH, approval number 13-C-0152, and was conducted …

522 A clinical study on iNeo-Vac-P01: a personalized neoantigen immunotherapy for postoperative recurrence prevention in pancreatic cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

95.3%

Zhejiang Provincial People’s Hospital iNeo-Vac-P01 pancreatic ductal adenocarcinoma (PDAC)

…n-label, single-arm clinical trial ( NCT04810910), conducted at Zhejiang Provincial People’s Hospital, enrolled PDAC patients who initiated treatment with iNeo-Vac-P…

536 Phase 1 trial of tumor-infiltrating lymphocyte (TIL) therapy in recurrent glioblastoma: A single-center experience using cells derived from primary surgical specimens

jitc · abstract · 2025-11-04 · 2 matching annotations

97.5%

Second Affiliated Hospital of Soochow University The Second Affiliated Hospital of Soochow University cyclophosphamide hydroxychloroquine Glioblastoma left frontal lobe glioblastoma sintilimab Innovent GB

… open-label, nonrandomized clinical trial ( NCT04943913) at the Second Affiliated Hospital of Soochow University to evaluate the safety and efficacy of TIL therapy in recurrent…

537 Targeting diffuse intrinsic pontine glioma with IL-7Rα-enhanced B7-H3 (CMD03) chimeric antigen receptor T cell: preliminary results from phase 1 clinical trial

jitc · abstract · 2025-11-04 · 2 matching annotations

97.0%

Chulalongkorn University Cancer Immunol Immunother dexamethasone CMD03 anakinra B7-H3 Diffuse intrinsic pontine glioma (DIPG)B7-H3-targeting DIPG

…DIPG ( NCT06221553). Approval was granted by the IRB committee, Chulalongkorn University (COA#1647/2024). Dose levels include 1×107, 3×107, and 1×108 CA…

54 Development and characterization of cytokine-based classifiers to predict response to immunotherapy using an ex vivo live tumor fragment platform

jitc · abstract · 2025-11-04 · 2 matching annotations

79.9%

Voabil et al.NCT05478538 αPD-1 αPD-L1 αCTLA-4

…ovide external validation of a weighted classifier published by Voabil et al.1 for predicting response to PD-1 blockade. Additionally, we tra…

552 Feasibility and tolerability of a CD4 re-directed chimeric antigen receptor T cell therapy (CD4CAR) in hematological malignancies: Initial results from multi-institutional first-in-human (FIH) trials

jitc · abstract · 2025-11-04 · 2 matching annotations

98.3%

Indiana University University of Miami FDA AML bendamustine acute myeloid leukemias chronic myelomonocytic leukemia fludarabine/cyclophosphamide TCM venetoclax+3 more

…CT06197672Ethics Approval The study obtained ethics approval by Indiana University and University of Miami IRB and participants gave informed cons…

553 A phase I clinical trial of allogeneic NKT cells expressing a CD19-specific CAR in patients with relapsed or refractory B cell malignancies: an interim analysis

jitc · abstract · 2025-11-04 · 2 matching annotations

94.1%

Baylor College of Medicine BCM graft-versus-host disease B cell malignancies IL-15 ALL-1 NHL-2 ALL-3

…al This study was approved by the Institutional Review Board at Baylor College of Medicine (BCM; H-44526).…

556 Transposon-based BAFF CAR-T cells (LMY-920) for treatment of non-hodgkin lymphoma (NHL), chronic lymphocytic lymphoma (CLL) and multiple myeloma (MM)

jitc · abstract · 2025-11-04 · 2 matching annotations

92.2%

Case Comprehensive Cancer Center Cleveland Clinic’s Institutional Review Board fludarabine lymphoma myeloma cyclophosphamide LMY-920 systemic lupus erythematosus MM DLBCL+2 more

…06916767Ethics Approval The study obtained ethics approval from Case Comprehensive Cancer Center, Cleveland Clinic’s Institutional Review Board (24-424/MOD01553…

560 Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in bilateral lung transplantation: case series

jitc · abstract · 2025-11-04 · 2 matching annotations

97.1%

Northwestern Memorial Hospital Northwestern University durvalumab atezolizumab bilateral non-small cell lung cancer toripalimab nivolumab COPD cemiplimab colorectal cancer+4 more

…o underwent bilateral orthotopic lung transplantation (BOLT) at Northwestern Memorial Hospital (Sep 2021-May 2025) after at least one cycle of ICI therapy. Pa…

580 Phase 1 study of mitotic checkpoint inhibitor BAL0891 in combination with tislelizumab (anti-PD-1 antibody) in patients with advanced solid tumors

jitc · abstract · 2025-11-04 · 2 matching annotations

86.5%

Cancer Res 2025 BAL0891 tislelizumab triple-negative breast cancer TTK-CS-101

…2164. https://doi.org/10.1158/1538-7445.AM2025-2164Wang, et al. Cancer Res 2025;85(8_Supplement_1):2169. https://doi.org/10.1158/1538-7445.AM20…

582 First-in-human phase 1/2 study of the integrin αvβ8-blocking antibody CRB-601 in patients with solid tumors

jitc · abstract · 2025-11-04 · 2 matching annotations

80.1%

Cedars-Sinai Medical Center Stephenson Cancer Center CRB-601 ovarian cancer head and neck squamous cell carcinoma melanoma

…University Hospital Cleveland University Hospitals IRB 20241088 Cedars-Sinai Medical Center Cedars-Sinai Office of Research Compliance and Quality Improvem…

583 Intrathecal PD-1 inhibitor combined with pemetrexed for leptomeningeal metastases from solid tumors: preliminary results from a phase I/II study (NCT 06462222)

jitc · abstract · 2025-11-04 · 2 matching annotations

91.2%

Guangzhou Medical University Affiliated Huizhou Hospital pemetrexed non-small cell lung cancer solid tumors small cell lung cancer Intrathecal PD-1 inhibitor breast cancer involved-field radiotherapy leptomeningeal metastases+1 more

… Institutional Review Board of the Affiliated Huizhou Hospital, Guangzhou Medical University, Huizhou, China (Approval number: 2024-KY-029-01). Informed con…